RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,000 | +22.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $9,840 | +172.1% | 4,000 | +150.0% | 0.00% | +200.0% |
| Q1 2023 | $3,616 | -35.2% | 1,600 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $5,584 | -90.5% | 1,600 | 0.0% | 0.00% | -88.9% |
| Q3 2022 | $59,000 | +96.7% | 1,600 | 0.0% | 0.02% | +100.0% |
| Q2 2022 | $30,000 | -30.2% | 1,600 | 0.0% | 0.01% | -18.2% |
| Q1 2022 | $43,000 | +19.4% | 1,600 | 0.0% | 0.01% | +22.2% |
| Q4 2021 | $36,000 | -14.3% | 1,600 | 0.0% | 0.01% | -25.0% |
| Q3 2021 | $42,000 | -17.6% | 1,600 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $51,000 | -8.9% | 1,600 | 0.0% | 0.01% | -6.7% |
| Q1 2021 | $56,000 | +9.8% | 1,600 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $51,000 | +8.5% | 1,600 | 0.0% | 0.02% | 0.0% |
| Q3 2020 | $47,000 | – | 1,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,270,072 | $61,269,000 | 9.93% |
| GREAT POINT PARTNERS LLC | 790,000 | $21,322,000 | 5.15% |
| ACUTA CAPITAL PARTNERS, LLC | 342,000 | $9,231,000 | 4.31% |
| COWEN AND COMPANY, LLC | 1,164,361 | $31,426,000 | 3.02% |
| Altium Capital Management LP | 206,000 | $5,560,000 | 1.86% |
| BVF INC/IL | 1,647,400 | $44,463,000 | 1.78% |
| RTW INVESTMENTS, LP | 2,540,074 | $68,557,000 | 1.42% |
| Vivo Capital, LLC | 705,882 | $19,052,000 | 1.31% |
| RA Capital Management | 2,000,000 | $53,980,000 | 1.18% |
| SPHERA FUNDS MANAGEMENT LTD. | 291,252 | $7,861,000 | 1.11% |